Clin Res Cardiol. 2022;111(3):284-293.
Hypertension control and end-stage renal disease in atrial fibrillation: a nationwide population-based cohort study.
제1저자 권순일, 이소령 · 교신저자 최의근
소속 (8)
- Department of Internal Medicine, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul, 03080, Republic of Korea.
- Department of Internal Medicine, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul, 03080, Republic of Korea. choiek17@snu.ac.kr.
- Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea. choiek17@snu.ac.kr.
- Department of Medical Statistics, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
- Department of Statistics and Actuarial Science, Soongsil University, Seoul, Republic of Korea.
- Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
- Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Chest and Heart Hospital, Liverpool, UK.
- Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
Abstract
BACKGROUND The impact of hypertension control on the risk of end-stage renal disease (ESRD) in patients newly diagnosed with atrial fibrillation (AF) is unknown. This study aimed to investigate the impact of hypertension control on incident ESRD among AF patients.
METHODS From the National Health Information database of Korea, we identified ESRD-free patients who were newly diagnosed with AF during 2010 and 2016. The patients were divided into four groups (NN, NH, HN, and HH) according to combinations of dichotomous blood pressure status [normotensive (N) or hypertensive (H)] of two consecutive check-ups. The primary outcome was incident ESRD. Cox proportional hazard regression analysis evaluated ESRD risks across the groups. The association between ESRD risks and changes in blood pressures was also evaluated.
RESULTS During the mean follow-up duration of 3.2 ± 1.9 years, 130,259 ESRD-free patients with AF (mean age 63.1 ± 12.1 years, male 61.2%) were evaluated. Compared to NN, other patient groups showed higher ESRD risks [hazard ratio (95% confidence interval) = 1.43 (1.08-1.89), 1.39 (1.08-1.79), and 2.03 (1.55-2.65) for NH, HN, and HH, respectively]. There was a significant trend of decreasing risks of ESRD in patients with greater reductions in systolic blood pressure after AF diagnosis (p for-trend < 0.001). The association between hypertension control and the ESRD risk was more accentuated in patients with chronic kidney disease.
CONCLUSION Uncontrolled hypertension was associated with an increased risk of incident ESRD in patients with newly diagnosed AF. This study emphasizes the importance of blood pressure control once patients are diagnosed with AF to prevent ESRD.
© 2021. Springer-Verlag GmbH Germany, part of Springer Nature.
Keywords
Atrial fibrillationBlood pressureEnd-stage renal diseaseHypertensionPrevention
그 밖의 정보
- 출판 형태
- Journal Article
- 저널
- Clinical research in cardiology : official journal of the German Cardiac Society · eISSN 1861-0692
- 전자 출판
- 2021-07-03
- MeSH
- Aged · Atrial Fibrillation / complications / physiopathology · Blood Pressure · Databases, Factual · Female · Follow-Up Studies · Humans · Hypertension / complications / therapy · Incidence · Kidney Failure, Chronic / epidemiology / etiology · Male · Middle Aged · Proportional Hazards Models · Republic of Korea / epidemiology
- 연구비
- the Korea Medical Device Development Fund grant funded by the Korea government (the Ministry of Science and ICT, the Ministry of Trade, Industry and Energy, the Ministry of Health & Welfare, Republic of Korea, the Ministry of Food and Drug Safety) 202013B14 · the Korea National Research Foundation funded by the Ministry of Education, Science and Technology 2020R1F1A106740
- 참고문헌
- 17편